Attached files

file filename
EX-31 - EXHIBIT 31 - Tengjun Biotechnology Corp.ex312.htm
EX-32 - EXHIBIT 32 - Tengjun Biotechnology Corp.ex322.htm
EX-31 - EXHIBIT 31 - Tengjun Biotechnology Corp.ex311.htm
EX-32 - EXHIBIT 32 - Tengjun Biotechnology Corp.ex321.htm
EXCEL - IDEA: XBRL DOCUMENT - Tengjun Biotechnology Corp.Financial_Report.xls

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-K/A


[X] ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


For the fiscal year ended: December 31, 2012


or

[  ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


For the transition period from ________ to ________


Commission File Number: 333-169397


China Herb Group Holdings Corporation

(Formerly known as “Island Radio, Inc.”)

 (Exact name of small business issuer as specified in its charter)

 

 

 

                          Nevada                           

(State or other jurisdiction

of incorporation)

           333-169397     

(Commission

File Number)

            27-3042462

(I.R.S. Employer

Identification Number)


4th Floor, Airport Industrial Park Business Center,

No.35 Changjiang South Road, New District,

Wuxi City, Jiangsu Province, China

 (Address of principal executive offices and zip code)


Phone: +86 13909840703

 (Registrant’s telephone number, including area code)


Copy of Communications To:

Bernard & Yam, LLP

401 Broadway, Suite 1708

New York, NY 10013

Phone: 212-219-7783

Facsimile: 212-219-3604


Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the last 90 days.  YES [X] NO [  ]


Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulations S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).   YES [X] NO [  ]


Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer, “accelerated filer,” “non-accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.


Large accelerated filer 

[  ] 

Accelerated filer 

[  ]

Non-accelerated filer 

[  ] 

Smaller reporting company 

[X]




Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

YES [X] NO  [  ]


The aggregate market value of the voting and non-voting stock (300,000 shares of common stock) held by non-affiliates of the registrant, as of April 22, 2013, was $0, computed by reference to the stock price of $0.00 per share on April 22, 2013.  All executive officers and directors of the registrant have been deemed, solely for the purpose of the foregoing calculation, to be "affiliates" of the registrant.


State the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date: 4,300,000 Shares of Common Stock, as of April 22, 2013.

 

_________________________________________________________________________________________________


EXPLANATORY NOTE

 

The sole purpose of this Amendment No. 1 to  China Herb Group Holdings Corporation's Form 10-K (the “Report”) for the fiscal year ended December 31, 2012, as filed with the Securities and Exchange Commission on May 1, 2013, is to furnish Exhibit 101 to the Report in accordance with Rule 405 of Regulation S-T. Exhibit 101 provides the financial statements and related notes from the Report formatted in XBRL (eXtensible Business Reporting Language).

 

No other changes have been made to the Report. This Amendment No. 1 to the Report does not reflect events that may have occurred subsequent to the original filing date, and does not modify or update in any way the disclosures made in the original Report.



Item 15.  Exhibits, Financial Statements Schedules


The following documents are filed as a part of this Amendment to Annual Report:

(3)

 

 

 

Exhibit Number

 


Description of Exhibit

 

 

 

3.1*

 

Articles of Incorporation

3.2*

 

Bylaws

31.1

 

Section 302 Certifications under Sarbanes-Oxley Act of 2002

32.1

 

Section 906 Certification under Sarbanes Oxley Act of 2002

101**

 

The following materials from our Annual Report on Form 10-K for the year ended December 31, 2011, formatted in XBRL (eXtensible Business Reporting Language): (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Operations, (iii) the Consolidated Statements of Stockholders' Equity (iv) the Consolidated Statements of Cash Flows, and (v) Notes to Consolidated Financial Statements. 

 

 

101.INS****      XBRL Instance

 

 

101.SCH****     XBRL Taxonomy Extension Schema

 

 

101.CAL****     XBRL Taxonomy Extension Calculation

 

 

101.DEF****      XBRL Taxonomy Extension Definition

 

 

101.LAB****     XBRL Taxonomy Extension Labels

 

 

101.PRE****      XBRL Taxonomy Extension Presentation


* Incorporated by our Registration Statement on Form S-1/A filed October 12, 2010.


** XBRL information is furnished and not filed or a part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.






Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


SIGNATURES


China Herb Group Holdings Corporation

(Registrant)

 

By: 

/s/ Qiuping Lu 

       

               Qiuping Lu

President, Director, CEO, CFO


Date:

May 10, 2013